Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Symbicort in asthma
NCT00651768Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Aug 2003; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00651768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651768.